ClinicalTrials.gov
ClinicalTrials.gov Menu

Breast Cancer and Chemo-amennorhea (chemo-ameno)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01867229
Recruitment Status : Unknown
Verified May 2013 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.
Recruitment status was:  Recruiting
First Posted : June 3, 2013
Last Update Posted : June 3, 2013
Sponsor:
Information provided by (Responsible Party):
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Brief Summary:
Relation between chemotherapy and amennorhea

Condition or disease Intervention/treatment
Breast Cancer Other: observational

Study Type : Observational
Estimated Enrollment : 500 participants
Time Perspective: Prospective
Official Title: Etude Prospective Multicentrique de l'aménorrhée Chimio-induite et de sa réversibilité Dans le Cancer du Sein Chez Des Patientes préménopausées Recevant Une chimiothérapie Adjuvante ou néoadjuvante. Etude Améno-Chimio.
Study Start Date : October 2011
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer

Group/Cohort Intervention/treatment
FEC- TC
Fluorouracil- Epiadriamycine- Cyclophosphamide Taxotère-Cyclophosphamide
Other: observational
standard of care fore patients with non metastatic breast cancer




Primary Outcome Measures :
  1. incidence and duration of the amenorrhea induced by chemotherapy [ Time Frame: 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
pre-menauposal breast cancer treated with chemotherapy
Criteria

Inclusion Criteria:

pre-menauposal breast cancer needed to be treat with chemotherapy -

Exclusion Criteria:

metastases menopausal


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01867229


Contacts
Contact: jean-pascal Machiels, PhD +32 2 764 54 57 jean-pascal.machiels@uclouvain.be
Contact: Nathalie Blondeel +32 2 764 42 14 nathalie.blondeel@uclouvain.be

Locations
Belgium
Clinique Saint Vincent Not yet recruiting
Rocourt, Liège, Belgium, 4000
Contact: Michel Masson         
Principal Investigator: Michel Masson         
Cliniques Universitaires Saint-Luc Recruiting
Brussels, Belgium, 1200
Contact: Martine Berlière    +32 2 7641075    martine.berlière@uclouvain.be   
Contact: Nathalie Blondeel    +32 2 764 42 14    nathalie.blondeel@uclouvain.be   
Principal Investigator: Martine Berlière         
Centre Hospitalier Université de Liège Not yet recruiting
Liège, Belgium, 4000
Contact: Eric Lifrange       elifrange@chu.ulg.ac.be   
Principal Investigator: Eric Lifrange         
CHR Citadelle Not yet recruiting
Liège, Belgium, 4000
Contact: Annelore Barbeaux       annelore.barbeaux@chrcitadelle.be   
Principal Investigator: Annelore Barbeaux         
Centre hospitalier Peltzer La Tourelle Recruiting
Verviers, Belgium, 4800
Contact: Anne-Lore Barbeaux, MD       annelore.barbeaux@chrcitadelle.be   
Principal Investigator: Anne-Lore Barbeaux, MD         
France
Institut Claudius Renaud Recruiting
Toulouse, France, 31059
Contact: Henri Roche       roche.henri@claudiusregaud.fr   
Principal Investigator: Henri Roche         
Principal Investigator: Florence Dalenc         
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Principal Investigator: jean-Pascal Machiels UCL-Saint Luc

Responsible Party: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier: NCT01867229     History of Changes
Other Study ID Numbers: UCL-gyneco-001
First Posted: June 3, 2013    Key Record Dates
Last Update Posted: June 3, 2013
Last Verified: May 2013

Keywords provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:
pre-menauposal
neo-adjuvant or adjuvant chemotherapy
no metastases

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases